Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Mar 31, 2025
Revenue declined in the current quarter compared to both the prior quarter and the same quarter a year ago. The decrease reflects lower net product sales, partially offset by a slight increase in alliance and other revenues.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue declined in the current quarter compared to both the prior quarter and the same quarter a year ago. The decrease reflects lower net product sales, partially offset by a slight increase in alliance and other revenues.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.2B
Revenue reported for this quarter.
Quarter-over-quarter
-9.2%
Change from the immediately preceding quarter.
Year-over-year
-5.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$47.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $12.2B | +8.7% |
| Sep 30, 2024 | $11.9B | +8.4% |
| Dec 31, 2024 | $12.3B | +7.5% |
| Mar 31, 2025 | $11.2B | -5.6% |
Revenue performance
Total revenues fell from the immediately preceding quarter, continuing a downward trend after three consecutive quarters of growth. The year-over-year comparison also shows a decline, with net product sales lower than the same period last year.
Quarterly comparison
Compared to the prior quarter, revenue decreased, reversing the prior quarter's increase. On a year-over-year basis, revenue was also lower, marking the first decline after three quarters of year-over-year growth.
What to watch
Monitor whether the decline in net product sales persists in the coming quarters, as it was the primary driver of the revenue decrease.